All Press Releases for January 21, 2022

Marquis Who's Who Honors Kenneth Blum with Inclusion in Who's Who in the World

With over 110 patents worldwide, Dr. Blum has contributed enormously to the fields of psychology, psychiatry and neurology

A prolific scientist, Dr. Blum has authored and co-authored over 675 articles and 18 books.

    AUSTIN, TX, January 21, 2022 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to honor Kenneth Blum with inclusion in Who's Who in the World. An accomplished listee, Kenneth Blum celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

For more than five decades, Dr. Blum has led a successful career in the field of medicine. He began his professional journey as a research scientist at the Southwest Research Institute in 1968. Thereafter, he garnered further experience as a professor at the University of Texas Health Science Center at San Antonio from 1972 to 1995. Since then, Dr. Blum has worked with a number of companies in various scientific fields.

Between 1995 and 2001, Dr. Blum served as the chairman, director and president of 1899 Ltd. A multi-million dollar company that was located in San Antonio, Texas. He has been called upon as the chief scientific officer of numerous organizations, including Health Thru Nutrition, Salugen Inc., LifeGen Inc., IGENE, Victory Nutrition International LLC and IVtalize Inc. He currently holds several roles, including as an adjunct research professor in the Wake Forest School of Medicine department of physiology and pharmacology, the chief executive officer and president of Synaptamine Inc., the director of LifeGen Inc., the chief scientific advisor of Dominion Diagnostics, the founding president of the United Scientific Science Group and the executive chairman of InGeneUs Inc. Notably, Dr. Blum has worked as an honorary lifetime professor of psychology at the Institute of Psychology at Eötvös Loránd University in Budapest, Hungary, since 2016.

Having held several positions in the fields of psychiatry and neuroscience, Dr. Blum has acted as the chairman of the eponymous Kenneth Blum Neurogenetic and Behavioral Institute since 2020. A respected voice in his field, he was further recruited to serve as an editorial board member for a number of renowned professional publications, including Theoretical Biology and Medical Modelling, the Open Obesity Journal, Functional Neurology, Trends in Applied Sciences Research and the Journal of Psychoactive Drugs. Likewise, Dr. Blum maintained involvement as the Editor-Chief of the Journal of Current Psychopharmacology and the editor in chief of the Journal of Reward Deficiency Syndrome and Addiction Science and Co-Editor in-Chief of The Journal of Systems and Integrative Neuroscience.

A prolific scientist, Dr. Blum has authored and co-authored over 675 articles and 18 books, including "Handbook of Abusable Drugs," "Staying Clean & Sober," "Overload: Attention Deficit Disorder and the Addictive Brain" and "Molecular Neurobiology of Addiction Recovery." Having extensively studied the science of addiction, he discovered the first gene association for alcoholism, which is a dopamine receptor gene. Moreover, Dr. Blum extensively researched the pharmacogenomics both substance and non-substance craving and completed important research regarding common generics threads for compulsive, addictive and impulsive behaviors.

Renowned for his contributions to the field, Dr. Blum holds twenty-two European patents, including the first patent on nutrigenomics ever awarded in the United States and Europe. He is known for coining the phrases "reward deficiency syndrome" and "brain rewarded cascade," which are widely used in his field. He has even been deemed the "father of psychiatric genetics" and the "father of neuroadaptagen amino-acid therapy." As a testament to his expertise, he has been the recipient of the Psychiatry Selection Award for "Handbook of Psychiatric Genetics" and the Book of the Month award for "Handbook of Abusable Drugs." Likewise, Dr. Blum earned the Julius Axelrod Distinguished Speaker Award.

Dr. Blum initially pursued a formal education at Columbia University, from which he graduated with a Bachelor of Science. He subsequently obtained a Master of Science from the New Jersey Medical School at Rutgers, the State University of New Jersey. In 1968, Dr. Blum earned a Doctor of Philosophy from New York Medical College. He has been honored with a DOCTOR OF HUMANE LETTERS from St .Martins University. He is a licensed pharmacist in the states of Texas and New York.

About Marquis Who's Who®
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at

# # #

Contact Information

-- --
Marquis Who's Who Ventures LLC
Uniondale, NY
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: